NASDAQ-GS · traded in Congress
Vertex Pharmaceuticals VRTX
$508.34 -8.00 (-1.55%) Sep 17, 2026
Market value$128.8B
P/E ratio-
Analyst target$580.50
52-week range-
Avg volume1,168,004
Dividend yieldN/A
Chart
Congress trades in VRTX
Members of Congress disclosed 2 transactions in VRTX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/26/2026 | David J. Taylor OH02 | Sale | $1,001 - $15,000 | 9/5/2026 filing |
| 01/29/2026 | David J. Taylor OH02 | Sale | $1,001 - $15,000 | 2/2/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.